Anfibatide ( DrugBank: Anfibatide )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
64	血栓性血小板減少性紫斑病	1

64. 血栓性血小板減少性紫斑病

臨床試験数 : 86 / 薬物数 : 81 - (DrugBank : 20) / 標的遺伝子数 : 16 - 標的パスウェイ数 : 63

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04021173 (ClinicalTrials.gov)	July 2019	15/7/2019	A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)	A Multicenter, Randomized, Double-blind, Placebo-parallel, Phase II Clinical Trial of the Efficacy a ...	Acquired Thrombotic Thrombocytopenic Purpura	Drug: Anfibatide;Drug: Placebos	Lee's Pharmaceutical Limited	NULL	Not yet recruiting	18 Years	N/A	All	74	Phase 2	China

First Previous1Next Last